
Jason A. Deck
Examiner (ID: 9672, Phone: (571)270-5753 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627 |
| Total Applications | 619 |
| Issued Applications | 298 |
| Pending Applications | 2 |
| Abandoned Applications | 319 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17306254
[patent_doc_number] => 11207336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Compositions and methods for treating an infection
[patent_app_type] => utility
[patent_app_number] => 16/846983
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23240
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16846983
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/846983 | Compositions and methods for treating an infection | Apr 12, 2020 | Issued |
Array
(
[id] => 16188591
[patent_doc_number] => 20200229440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => HIGHLY DISPERSIBLE ANTI-MICROBIAL AND ADHESION AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/839678
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 394
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839678
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/839678 | HIGHLY DISPERSIBLE ANTI-MICROBIAL AND ADHESION AGENTS | Apr 2, 2020 | Abandoned |
Array
(
[id] => 16176252
[patent_doc_number] => 20200223220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => COMPOUNDS FOR THE TREATMENT OF MALARIA
[patent_app_type] => utility
[patent_app_number] => 16/827776
[patent_app_country] => US
[patent_app_date] => 2020-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827776
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/827776 | COMPOUNDS FOR THE TREATMENT OF MALARIA | Mar 23, 2020 | Abandoned |
Array
(
[id] => 16296192
[patent_doc_number] => 20200281915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => TRANSORAL DOSAGE FORMS COMPRISING SUFENTANIL AND NALOXONE
[patent_app_type] => utility
[patent_app_number] => 16/790207
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/790207 | TRANSORAL DOSAGE FORMS COMPRISING SUFENTANIL AND NALOXONE | Feb 12, 2020 | Abandoned |
Array
(
[id] => 15993183
[patent_doc_number] => 20200172462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => SUBSTITUTED AROMATIC COMPOUNDS AND RELATED METHOD FOR THE TREATMENT OF FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/780316
[patent_app_country] => US
[patent_app_date] => 2020-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16780316
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/780316 | Substituted aromatic compounds and related method for the treatment of fibrosis | Feb 2, 2020 | Issued |
Array
(
[id] => 15928111
[patent_doc_number] => 20200155689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/751154
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751154
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/751154 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | Jan 22, 2020 | Abandoned |
Array
(
[id] => 15928113
[patent_doc_number] => 20200155690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/751158
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751158
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/751158 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | Jan 22, 2020 | Abandoned |
Array
(
[id] => 16946607
[patent_doc_number] => 20210205298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => METHODS OF TREATING RADIATION INDUCED GASTROINTESTINAL SYNDROME (RIGS) AND RELATED DISEASE STATES USING COMPOUND 512
[patent_app_type] => utility
[patent_app_number] => 16/736805
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16736805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/736805 | Methods of treating radiation induced gastrointestinal syndrome (RIGS) and related disease states using compound 512 | Jan 6, 2020 | Issued |
Array
(
[id] => 16946607
[patent_doc_number] => 20210205298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => METHODS OF TREATING RADIATION INDUCED GASTROINTESTINAL SYNDROME (RIGS) AND RELATED DISEASE STATES USING COMPOUND 512
[patent_app_type] => utility
[patent_app_number] => 16/736805
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16736805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/736805 | Methods of treating radiation induced gastrointestinal syndrome (RIGS) and related disease states using compound 512 | Jan 6, 2020 | Issued |
Array
(
[id] => 16504686
[patent_doc_number] => 20200383942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => Alkylamido Compounds and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/733349
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16733349
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/733349 | Alkylamido Compounds and Uses Thereof | Jan 2, 2020 | Abandoned |
Array
(
[id] => 17028500
[patent_doc_number] => 11090298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Method for treating movement disorders with befiradol
[patent_app_type] => utility
[patent_app_number] => 16/717019
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7770
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16717019
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/717019 | Method for treating movement disorders with befiradol | Dec 16, 2019 | Issued |
Array
(
[id] => 17043757
[patent_doc_number] => 11096916
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Use of nicotinic acetylcholine receptor alpha 7 activators
[patent_app_type] => utility
[patent_app_number] => 16/703501
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12381
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16703501
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/703501 | Use of nicotinic acetylcholine receptor alpha 7 activators | Dec 3, 2019 | Issued |
Array
(
[id] => 16008939
[patent_doc_number] => 20200179312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => ANALOGUES OF CYSTEAMINE AS THERAPEUTIC AGENTS FOR CYSTIC FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/691647
[patent_app_country] => US
[patent_app_date] => 2019-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691647
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/691647 | ANALOGUES OF CYSTEAMINE AS THERAPEUTIC AGENTS FOR CYSTIC FIBROSIS | Nov 21, 2019 | Abandoned |
Array
(
[id] => 16389507
[patent_doc_number] => 20200330448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT RELATED TO FALL AND FALL FREQUENCY IN NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/693098
[patent_app_country] => US
[patent_app_date] => 2019-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16693098
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/693098 | COMPOSITIONS AND METHODS FOR TREATMENT RELATED TO FALL AND FALL FREQUENCY IN NEURODEGENERATIVE DISEASES | Nov 21, 2019 | Abandoned |
Array
(
[id] => 15646605
[patent_doc_number] => 20200085832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => DEUTERATED ANALOGS OF AN ORGANIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/692217
[patent_app_country] => US
[patent_app_date] => 2019-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16692217
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/692217 | DEUTERATED ANALOGS OF AN ORGANIC COMPOUND | Nov 21, 2019 | Abandoned |
Array
(
[id] => 15586389
[patent_doc_number] => 20200069729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => Combination Therapy for Treating Proliferative Diseases
[patent_app_type] => utility
[patent_app_number] => 16/679193
[patent_app_country] => US
[patent_app_date] => 2019-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16679193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/679193 | Combination Therapy for Treating Proliferative Diseases | Nov 8, 2019 | Abandoned |
Array
(
[id] => 15765987
[patent_doc_number] => 20200114011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => AQUEOUS DRUG DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/658524
[patent_app_country] => US
[patent_app_date] => 2019-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16658524
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/658524 | AQUEOUS DRUG DELIVERY SYSTEM | Oct 20, 2019 | Abandoned |
Array
(
[id] => 17014081
[patent_doc_number] => 11083700
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-10
[patent_title] => Butyrate salts for use in inflammatory diseases
[patent_app_type] => utility
[patent_app_number] => 16/600660
[patent_app_country] => US
[patent_app_date] => 2019-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6997
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16600660
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/600660 | Butyrate salts for use in inflammatory diseases | Oct 13, 2019 | Issued |
Array
(
[id] => 15492939
[patent_doc_number] => 20200046658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => PHARMACEUTICAL COMPOSITION FOR INDUCING EXERCISE MIMETIC EFFECT
[patent_app_type] => utility
[patent_app_number] => 16/591713
[patent_app_country] => US
[patent_app_date] => 2019-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16591713
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/591713 | PHARMACEUTICAL COMPOSITION FOR INDUCING EXERCISE MIMETIC EFFECT | Oct 2, 2019 | Abandoned |
Array
(
[id] => 15451039
[patent_doc_number] => 20200038343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => METHODS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/580914
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16580914
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/580914 | Methods for treating cancer | Sep 23, 2019 | Issued |